Abarceo is a preclinical stage company. The company has expertise in the molecular and genetic causes of beta cell dysfunction in type 2 diabetes and has identified a novel diabetes target responsible for the dysfunction, VDAC-1. By blocking VDAC-1 with a small molecule blocker beta cells are returned to a functional state in a durable and disease modifying manner allowing patients to produce sufficient insulin, naturally. The company is fundraising to support preclinical development.
| Website | http://www.abarceo.com |
| Employees | 9 (4 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
PHP
+4 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Pharmaceuticals, Pharmaceutical, Health Care, Therapeutics |
| Keywords | Preclinical Development, Pharmaceutical, Diabetes Research, Pharmaceutical Research, Biotechnology, Type 2 Diabetes, Drug Development, Drug Discovery, Molecular Biology, Diabetes Treatment, Biopharma, Genetic Research, Life Sciences, Clinical Trials, Clinical Stage |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences +44 more (view full list) |
Looking for a particular Abarceo Pharma employee's phone or email?
Abarceo Pharma Questions
Adam Bruce is the CEO of Abarceo Pharma.
4 people are employed at Abarceo Pharma.
Top Abarceo Pharma Employees
Related Companies
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups.
Search the #1
Contact Database
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Use our
AI-Powered
Email Finder
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
